The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Rodman David Malcom since 2016.
This trader's CIK number is 1672659.
At the time of last reporting, Rodman David Malcom was the Chief Medical Officer of Mineralys Therapeutics, Inc.. (stock ticker symbol MLYS).
Also see all insider trading activities at Mineralys Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | MLYS | 0 | $0 | 112,600 | $1,703,086 | 57,413 | $58,930 |
| 2024 | MLYS | 0 | $0 | 31,133 | $467,845 | 153,828 | $132,532 |
| 2023 | MLYS | 0 | $0 | 231,716 | $2,994,400 | 246,768 | $175,667 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2017 | NVLS | 0 | $0 | 6,687 | $15,179 | 18,055 | $0 |
| 2016 | NVLS | 0 | $0 | 11,770 | $74,054 | 36,111 | $0 |
1. Mineralys Therapeutics, Inc. (MLYS)
2. Alpine Immune Sciences, Inc. (NVLS)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-08-12 | MLYS | Option Ex | 6,349 | 1.08 | 6,856 |
| 2025-08-13 | MLYS | Sale | 11,365 | 12.93 | 146,983 |
| 2025-07-14 | MLYS | Option Ex | 6,349 | 1.08 | 6,856 |
| 2025-07-14 | MLYS | Sale | 11,366 | 14.59 | 165,875 |
| 2025-06-13 | MLYS | Sale | 11,366 | 14.60 | 165,932 |
| 2025-06-12 | MLYS | Option Ex | 6,348 | 1.08 | 6,855 |
| 2025-05-14 | MLYS | Sale | 11,366 | 15.29 | 173,774 |
| 2025-05-12 | MLYS | Option Ex | 6,349 | 1.08 | 6,856 |
| 2025-04-14 | MLYS | Option Ex | 6,348 | 1.08 | 6,855 |
| 2025-04-14 | MLYS | Sale | 11,366 | 14.26 | 162,090 |
| 2025-04-01 | MLYS | Option Ex | 1,606 | 1.08 | 1,734 |
| 2025-04-01 | MLYS | Sale | 55,771 | 15.93 | 888,432 |
| 2025-03-12 | MLYS | Option Ex | 6,349 | 1.08 | 6,856 |
| 2025-02-12 | MLYS | Option Ex | 6,348 | 1.08 | 6,855 |
| 2025-01-13 | MLYS | Option Ex | 11,367 | .81 | 9,207 |
| 2024-12-11 | MLYS | Option Ex | 5,017 | .54 | 2,709 |
| 2024-11-11 | MLYS | Sale | 5,026 | 15.00 | 75,400 |
| 2024-11-11 | MLYS | Option Ex | 10,043 | .81 | 8,134 |
| 2024-11-06 | MLYS | Option Ex | 25,482 | 1.08 | 27,520 |
| 2024-11-06 | MLYS | Sale | 25,482 | 15.03 | 383,070 |
| 2024-10-14 | MLYS | Option Ex | 5,352 | 1.08 | 5,780 |
| 2024-10-11 | MLYS | Option Ex | 5,017 | .54 | 2,709 |
| 2024-09-11 | MLYS | Option Ex | 5,018 | .54 | 2,709 |
| 2024-09-12 | MLYS | Option Ex | 6,349 | 1.08 | 6,856 |
| 2024-08-12 | MLYS | Option Ex | 11,365 | .81 | 9,205 |
| 2024-07-16 | MLYS | Option Ex | 525 | 1.08 | 567 |
| 2024-07-16 | MLYS | Sale | 525 | 15.00 | 7,875 |
| 2024-07-11 | MLYS | Option Ex | 5,017 | .54 | 2,709 |
| 2024-07-12 | MLYS | Option Ex | 6,349 | 1.08 | 6,856 |
| 2024-06-11 | MLYS | Option Ex | 5,017 | .54 | 2,709 |
| 2024-06-12 | MLYS | Option Ex | 6,349 | 1.08 | 6,856 |
| 2024-05-13 | MLYS | Option Ex | 11,366 | .81 | 9,206 |
| 2024-05-09 | MLYS | Sale | 100 | 15.00 | 1,500 |
| 2024-05-09 | MLYS | Option Ex | 100 | 1.08 | 108 |
| 2024-04-11 | MLYS | Option Ex | 5,017 | .54 | 2,709 |
| 2024-04-12 | MLYS | Option Ex | 6,349 | 1.08 | 6,856 |
| 2024-03-11 | MLYS | Option Ex | 5,017 | .54 | 2,709 |
| 2024-03-12 | MLYS | Option Ex | 6,348 | 1.08 | 6,855 |
| 2024-02-12 | MLYS | Option Ex | 11,366 | .81 | 9,206 |
| 2024-01-12 | MLYS | Option Ex | 6,348 | 1.08 | 6,855 |
| 2024-01-11 | MLYS | Option Ex | 5,017 | .54 | 2,709 |
| 2023-12-11 | MLYS | Option Ex | 5,018 | .54 | 2,709 |
| 2023-11-03 | MLYS | Option Ex | 10,034 | .54 | 5,418 |
| 2023-08-11 | MLYS | Sale | 157,091 | 12.81 | 2,012,335 |
| 2023-08-10 | MLYS | Sale | 74,625 | 13.16 | 982,065 |
| 2023-08-11 | MLYS | Option Ex | 157,091 | .81 | 127,243 |
| 2023-08-10 | MLYS | Option Ex | 74,625 | .54 | 40,297 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2017-01-03 | NVLS | Option Ex | 18,055 | .00 | 0 |
| 2017-01-04 | NVLS | Sale | 6,687 | 2.27 | 15,179 |
| 2016-10-03 | NVLS | Option Ex | 18,056 | .00 | 0 |
| 2016-10-04 | NVLS | Sale | 5,820 | 7.96 | 46,327 |
| 2016-07-05 | NVLS | Sale | 5,950 | 4.66 | 27,727 |
| 2016-07-01 | NVLS | Option Ex | 18,055 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Rodman David Malcom (Chief Medical Officer of Mineralys Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.